267 related articles for article (PubMed ID: 10362413)
1. An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group.
Grover R; Zaccardelli D; Colice G; Guntupalli K; Watson D; Vincent JL
Crit Care Med; 1999 May; 27(5):913-22. PubMed ID: 10362413
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
[TBL] [Abstract][Full Text] [Related]
3. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Bakker J; Grover R; McLuckie A; Holzapfel L; Andersson J; Lodato R; Watson D; Grossman S; Donaldson J; Takala J;
Crit Care Med; 2004 Jan; 32(1):1-12. PubMed ID: 14707554
[TBL] [Abstract][Full Text] [Related]
4. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock.
López A; Lorente JA; Steingrub J; Bakker J; McLuckie A; Willatts S; Brockway M; Anzueto A; Holzapfel L; Breen D; Silverman MS; Takala J; Donaldson J; Arneson C; Grove G; Grossman S; Grover R
Crit Care Med; 2004 Jan; 32(1):21-30. PubMed ID: 14707556
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of the nitric oxide synthase inhibitor L-NG-methylarginine hydrochloride in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group.
Hussein Z; Beerahee M; Grover R; Jordan B; Jeffs R; Donaldson J; Zaccardelli D; Colice G; Guntupalli K; Watson D; Vincent JL
Clin Pharmacol Ther; 1999 Jan; 65(1):1-9. PubMed ID: 9951425
[TBL] [Abstract][Full Text] [Related]
6. Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study.
Avontuur JA; Tutein Nolthenius RP; van Bodegom JW; Bruining HA
Crit Care Med; 1998 Apr; 26(4):660-7. PubMed ID: 9559602
[TBL] [Abstract][Full Text] [Related]
7. Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study.
Kirov MY; Evgenov OV; Evgenov NV; Egorina EM; Sovershaev MA; Sveinbjørnsson B; Nedashkovsky EV; Bjertnaes LJ
Crit Care Med; 2001 Oct; 29(10):1860-7. PubMed ID: 11588440
[TBL] [Abstract][Full Text] [Related]
8. Effect of L-NAME, an inhibitor of nitric oxide synthesis, on cardiopulmonary function in human septic shock.
Avontuur JA; Tutein Nolthenius RP; Buijk SL; Kanhai KJ; Bruining HA
Chest; 1998 Jun; 113(6):1640-6. PubMed ID: 9631805
[TBL] [Abstract][Full Text] [Related]
9. Effects of norepinephrine plus dobutamine or norepinephrine alone on left ventricular performance of septic shock patients.
Martin C; Viviand X; Arnaud S; Vialet R; Rougnon T
Crit Care Med; 1999 Sep; 27(9):1708-13. PubMed ID: 10507587
[TBL] [Abstract][Full Text] [Related]
10. Aminoethyl-isothiourea, a nitric oxide synthase inhibitor and oxygen radical scavenger, improves survival and counteracts hemodynamic deterioration in a porcine model of streptococcal shock.
Saetre T; Höiby EA; Aspelin T; Lermark G; Egeland T; Lyberg T
Crit Care Med; 2000 Aug; 28(8):2697-706. PubMed ID: 10966238
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide synthase inhibition versus norepinephrine for the treatment of hyperdynamic sepsis in sheep.
Booke M; Hinder F; McGuire R; Traber LD; Traber DL
Crit Care Med; 1996 May; 24(5):835-44. PubMed ID: 8706462
[TBL] [Abstract][Full Text] [Related]
12. Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock.
Robertson FM; Offner PJ; Ciceri DP; Becker WK; Pruitt BA
Arch Surg; 1994 Feb; 129(2):149-55; discussion 155-6. PubMed ID: 7508219
[TBL] [Abstract][Full Text] [Related]
13. Methylene blue increases myocardial function in septic shock.
Daemen-Gubbels CR; Groeneveld PH; Groeneveld AB; van Kamp GJ; Bronsveld W; Thijs LG
Crit Care Med; 1995 Aug; 23(8):1363-70. PubMed ID: 7634806
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shock.
Kiehl MG; Ostermann H; Meyer J; Kienast J
Intensive Care Med; 1997 May; 23(5):561-6. PubMed ID: 9201529
[TBL] [Abstract][Full Text] [Related]
15. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study.
Levy B; Bollaert PE; Charpentier C; Nace L; Audibert G; Bauer P; Nabet P; Larcan A
Intensive Care Med; 1997 Mar; 23(3):282-7. PubMed ID: 9083230
[TBL] [Abstract][Full Text] [Related]
16. Effect of combined nitric oxide inhalation and NG-nitro-L-arginine infusion in porcine endotoxin shock.
Weitzberg E; Rudehill A; Modin A; Lundberg JM
Crit Care Med; 1995 May; 23(5):909-18. PubMed ID: 7736750
[TBL] [Abstract][Full Text] [Related]
17. Tissue oxygenation and hemodynamic response to NO synthase inhibition in septic shock.
Broccard A; Hurni JM; Eckert P; Liaudet L; Schaller MD; Lazor R; Perret C; Feihl F
Shock; 2000 Jul; 14(1):35-40. PubMed ID: 10909891
[TBL] [Abstract][Full Text] [Related]
18. High-dose vasopressin is not superior to norepinephrine in septic shock.
Klinzing S; Simon M; Reinhart K; Bredle DL; Meier-Hellmann A
Crit Care Med; 2003 Nov; 31(11):2646-50. PubMed ID: 14605537
[TBL] [Abstract][Full Text] [Related]
19. Selective iNOS inhibition is superior to norepinephrine in the treatment of rat endotoxic shock.
Rosselet A; Feihl F; Markert M; Gnaegi A; Perret C; Liaudet L
Am J Respir Crit Care Med; 1998 Jan; 157(1):162-70. PubMed ID: 9445295
[TBL] [Abstract][Full Text] [Related]
20. Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study.
Morelli A; Ertmer C; Lange M; Dünser M; Rehberg S; Van Aken H; Pietropaoli P; Westphal M
Br J Anaesth; 2008 Apr; 100(4):494-503. PubMed ID: 18308741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
